Evidence map›Paper›PMID 29074174›Full record

ArticlePapillomavirus research (Amsterdam, Netherlands)2016

Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts.

Tor Molden, Berit Feiring, Ole Herman Ambur, Irene K Christiansen, Mona Hansen, Ida Laake, Roger Meisal, Ellen Myrvang, Christine Monceyron Jonassen, Lill Trogstad

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Papillomavirus research (Amsterdam, Netherlands), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tor MoldenNorwegian Institute of Public Health, PO Box, 4404 Nydalen, 0403 Oslo, Norway. Electronic address: tor.molden@fhi.no.
Berit FeiringNorwegian Institute of Public Health, PO Box, 4404 Nydalen, 0403 Oslo, Norway. Electronic address: berit.feiring@fhi.no.
Ole Herman AmburAkershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway. Electronic address: ole.herman.ambur@ahus.no.
Irene K ChristiansenAkershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway. Electronic address: irene.kraus.christiansen@ahus.no.
Mona HansenAkershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway. Electronic address: mona.lindsethmo.hansen@ahus.no.
Ida LaakeNorwegian Institute of Public Health, PO Box, 4404 Nydalen, 0403 Oslo, Norway. Electronic address: ida.laake@fhi.no.
Roger MeisalAkershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway. Electronic address: roger.meisal@ahus.no.
Ellen MyrvangAkershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway. Electronic address: ellen.myrvang@ahus.no.
Christine Monceyron JonassenAkershus University Hospital, PO Box 1000, 1478 Lørenskog, Norway; Østfold Hospital Trust, PO Box 300, 1714 Grålum, Norway. Electronic address: christine.monceyron.jonassen@so-hf.no.
Lill TrogstadNorwegian Institute of Public Health, PO Box, 4404 Nydalen, 0403 Oslo, Norway. Electronic address: lill.trogstad@fhi.no.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of the current study was to assess the HPV prevalence in unscreened and unvaccinated young women living in Norway, to provide important baseline data for early estimation of the impact of the HPV vaccination program.

methodsA total of 13,129 self-sampled urine samples from two complete birth-cohorts of 17-year old women born in 1994 and 1996 and one third of a birth-cohort of 21-year old women born in 1990, were analysed for the presence of 37 HPV types using PCR and a DNA hybridization technique.

resultsIn the two birth cohorts of 17-year old women, HPV was detected in 19.9% (95% CI 18.8-20.9) and 15.4% (95% CI 14.5-16.3), respectively. High-risk HPV types were detected in 11.2% (95% CI 10.3-12.0) and 7.6% (95% CI 6.9-8.2), respectively, while vaccine types were detected in 7.4% (95% CI 6.7-8.1) and 6.0% (95% CI 5.4-6.6), respectively. Among the 21-year old women HPV was detected in 45.4% (95% CI 42.9-47.8), whereas high-risk types were detected in 29.8% (95% CI 27.5-32.0). Vaccine types (HPV 6, 11, 16, 18) were detected in 16.2% (95% CI 14.4-18.1).

conclusionThis large population based study confirms that HPV testing in urine samples is easy and highly feasible for epidemiological studies and vaccine surveillance in young women. HPV was very common and a broad spectrum of HPV types was identified. Differences in HPV prevalence was seen both between age groups and between the two birth cohorts of 17-year old women.

Indexed as

GenotypeAdolescentCross-Sectional StudiesFemaleHumansNorwayNucleic Acid HybridizationPapillomaviridaePapillomavirus InfectionsPolymerase Chain ReactionPrevalenceUrineYoung AdultHPV genotypeHPV prevalenceHuman papillomavirusImmunizationUrineVaccine

Identifiers

PMID29074174
PMCPMC5886875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.